Driving Thought Leadership. Forging Connections. Delivering Results.
New England arguably delivers the best ecosystem for launching, growing, and supporting biotech companies in North America. It leads the way in biotech VC funding as well as having a world-renowned academic reputation underpinning private industry's efforts.
With over 430 biotech companies registered in Massachusetts alone, the region is home to not only industry heavyweights and household names, but start-ups at the leading edge of drug discovery and the medical technologies of the future.
COG New England brings together senior decision-makers from across the spectrum of New England, and wider East Coast-based, trial sponsors to hear from thought leaders within the industry, regulators and academia alongside a group of the most trusted and innovative solution providers serving this market for two days of leading multi-stream agenda content and networking engagement at a luxury Boston hotel.
We're delighted to host COG New England as the premier meeting place for the New England clinical trial sector and look forward to welcoming you in Boston in April.